MPLX reinstated with an Underperform at BofA

BofA analyst Jean Ann Salisbury reinstated coverage of MPLX with an Underperform rating and $43 price target The firm sees lower growth in coming years and thinks MPLX can grow EBITDA in the “low single digits, not 10%,” the analyst tells investors. Participation in Blackcomb limits capex reduction in the near-term, suggesting limit to dividend growth in 2025/26, the analyst added.